Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01825252 · ClinicalTrials.gov registry record · NA

Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)

A NA study of HIV, sponsored by Medical College of Wisconsin.

Completed
Registry status
NA
Development phase
856
Enrollment target
2
Study locations

NCT01825252: Completed NA study of HIV, sponsored by Medical College of Wisconsin.

NCT01825252 is a NA study of HIV that has completed, run by Medical College of Wisconsin. The registered enrollment target is 856 participants, above the 437-participant average among 303 other HIV trials with a reported enrollment target (96% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01825252, a NA study of HIV, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
NA
Development phase
856 participants
Enrollment target
2
Study locations

Study Summary

During the formative research phase, investigators will undertake formative studies to locate, understand, and characterize high-risk social networks of African American MSM in the community; gain community participation, involvement, and input; and undertake interviews with key informants and community members to gain information needed to pilot test study recruitment procedures, measures, and intervention content. During a 4-year main outcome trial phase, the investigators will enroll 24 separate sociocentric ("bounded") social networks composed predominantly of Black MSM. Each sociocentric network will consist of the ring of friends surrounding an initial high-risk index as well as all friends surrounding persons in this second ring and then friends surrounding a successive third snowball ring of enrollees. Each 3-ring sociocentric network is expected to consist of approximately 40 unique members (n=24 networks, each with 40 members = approximately 960 individual participants). All participants will be assessed at baseline to measure sexual practices, substance use, and other risk characteristics over the past 3 months; asked to provide biological specimens to be tested for HIV and other sexually transmitted diseases (STDs); and counseled in HIV/STD risk reduction. STDs will be treated and those with HIV will be referred for treatment. The investigators will identify the individuals in intervention condition networks with the greatest number of reciprocal interconnections and the most favorable sociometric standing in the network. These individuals--expected to constitute approximately 20% of the sociocentric network and designated as network leaders--will be recruited to attend a 9-session program that provides training and guidance in how to deliver on-going, theoretically-based, and culturally tailored risk reduction advice and counseling to other members within the same network. Six and 18 months following the intervention, all participants will be reasse

Primary Outcome

We will compare the prevalence and frequency of unprotected anal intercourse with nonexclusive partners pre- and post-intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Social Network Intervention
  • BEHAVIORAL Counsel, Test, and Treat

Study Locations (2)

Ohio

  • AIDS TaskForce of Greater Cleveland - Cleveland

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 856 participants
Start Date 2011-08
Est. Completion 2017-12
Phase NA
Medical College of Wisconsin

447 total trials

What the finished NCT01825252 record still lists

NCT01825252 is an interventional study that assigns participants to a tested intervention. The registered 856 participants enrollment target is mid-sized for trials with a published cap, above the 437-participant average among 303 other HIV trials with a reported enrollment target (96% higher).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Social Network Intervention is the first listed.

NCT01825252 reports a single indexed study location in Ohio, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01825252 about?

NCT01825252 is a clinical study titled "Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)". During the formative research phase, investigators will undertake formative studies to locate, understand, and characterize high-risk social networks of African American MSM in the community; gain community participation, involvement, and input; and undertake interviews with key informants and commu...

What is the current status of trial NCT01825252?

This trial is currently completed. It is a NA study. The enrollment target is 856 participants. The study started on 2011-08. Estimated completion is 2017-12.

What conditions does trial NCT01825252 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01825252?

The interventions under investigation include: Social Network Intervention (BEHAVIORAL), Counsel, Test, and Treat (BEHAVIORAL).

Who is sponsoring clinical trial NCT01825252?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01825252 being conducted?

This trial has 2 study locations across Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01825252's enrollment target sits among peer trials

856 24th of 303 higher than 280 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06231485 · 856 participants · NA

    Socialization To Enrich Participation & Support Sexuality for Young People With I/DD

  • NCT05108896 · 855 participants · NA

    Aspiration in Acute Respiratory Failure Survivors 2

  • NCT07005102 · 854 participants · Phase 2

    A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • NCT07290491 · 854 participants · Phase 3

    Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01825252, the US trial registry maintained by the National Library of Medicine. NCT01825252 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.